🇺🇸 FDA
Patent

US 8779197

Aryl amides useful as inhibitors of voltage-gated sodium channels

granted A61PA61P1/00A61P13/10

Quick answer

US patent 8779197 (Aryl amides useful as inhibitors of voltage-gated sodium channels) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P1/00, A61P13/10, A61P19/02, A61P25/00